肿瘤体积对Ⅰ期非小细胞肺癌术后患者预后预测价值研究.docVIP

肿瘤体积对Ⅰ期非小细胞肺癌术后患者预后预测价值研究 　　[摘要] 目的 探讨肿瘤体积预测Ⅰ期非小细胞肺癌根治术后患者预后的价值。 方法 回顾性分析2007年1月～2010年12月收入中山大学肿瘤防治中心并接受根治性手术、术后病理为Ⅰ期非小细胞肺癌患者203例，比较肿瘤体积8.35 cm3和肿瘤体积≥8.35 cm3两组患者的总生存率和无病生存期，并纳入COX多因素分析。 结果 两组在性别、吸烟、病理类型、病理分期、分化程度、支气管壁侵犯方面比较，差异有统计学意义（P 0.05）。在多因素分析中，肿瘤体积是Ⅰ期非小细胞肺癌预后一个独立的预测因子（HR=2.972，95%CI：1.566～5.637，P 0.01）。生存分析结果显示肿瘤体积8.35 cm3患者5年总生存率为88.5%，肿瘤体积≥8.35cm3患者5年OS为74.0%（P 0.01）。肿瘤体积8.35 cm3预示更长的无病生存期（P 0.01）。 结论 肿瘤体积是Ⅰ期非小细胞肺癌OS和PFS的独立预测因素，术前CT测定肿瘤体积有助于评估患者的预后。 　　[关键词] 肿瘤体积；Ⅰ期非小细胞肺癌；预后 　　[中图分类号] R734.2 [文献标识码] A [文章编号] 1673-7210（2018）03（b）-0104-05 　　Study on prognostic predictive value of tumor volume in patients with stage Ⅰ non-small cell lung cancer 　　WEI Zhenqiang XIE Haojun SU Xiaodong 　　Department of Thoracic Surgery， Sun Yat-Sen University Cancer Center， Guangdong Province， Guangzhou 510060， China 　　[Abstract] Objective To investigate the value of tumor volume in predicting the prognosis of patients with stage I non-small cell lung cancer （NSCLC） after radical surgery. Methods Two hundred and Three patients with radical surgery and postoperative pathology was stage Ⅰ NSCLC from January 2007 to December 2010 in Sun Yat-sen University Cancer Center was retrospectively reviewed. The overall survival and disease-free survival in patients were compared between tumor volume 8.35 cm3 and tumor volume ≥8.35 cm3 through COX multivariate analysis. Results There were significant differences between the two groups in terms of characteristics of sex， smoking history， histological type， pathological stage， degree of differentiation and bronchial wall invasion （P 0.05）. In multivariate analysis， tumor volume was an independent predictor for the prognosis of stage I NSCLC （HR=2.972?? 95% CI：1.566-5.637， P 0.01）. Survival analysis showed that the 5 year overall survival rates （OS） was 88.5% and 74% in tumor volume 8.35 cm3 group and tumor volume ≥8.35 cm3 （P 0.01） respectively. Tumor volume 8.35 cm3 indicated a longer progress-free survival （P 0.01）. Conclusion Tu